Capmatinib and Osimertinib Combination Therapy for EGFR-Mutant Lung Adenocarcinoma

J Thorac Oncol. 2020 Jan;15(1):e13-e15. doi: 10.1016/j.jtho.2019.07.027.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acrylamides
  • Adenocarcinoma of Lung / drug therapy
  • Adenocarcinoma of Lung / genetics
  • Aniline Compounds
  • Benzamides
  • ErbB Receptors / genetics
  • Humans
  • Imidazoles
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / genetics
  • Mutation
  • Triazines

Substances

  • Acrylamides
  • Aniline Compounds
  • Benzamides
  • Imidazoles
  • Triazines
  • osimertinib
  • EGFR protein, human
  • ErbB Receptors
  • capmatinib